ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cisplatin Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-31G5682
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Cisplatin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cisplatin Market Research Report 2025

Code: QYRE-Auto-31G5682
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly and Company
Hospira
Pfizer Inc
Bedford Pharmaceuticals
Alvogen
Athenex Pharmaceutical
Gland Pharma (Fosun Pharma)
West Ward Pharmaceuticals
WG Critical Care
David Bull Laboratories
Omega Laboratories
Fresenius Kabi
TEVA
Mylan Pharmaceuticals
Yunnan Plant Pharmaceutical
Yunnan Biological Valley Pharmaceutical
Dezhou de Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Qilu Pharmaceutical

Cisplatin Market

The global market for Cisplatin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracyclic Chemicalbook or cross-linking with DNA, or it may form cross-linking with DNA and proteins, and inhibit cell mitosis. It is a non-specific drug in cell cycle, which can inhibit lymphocyte transformation in addition to anticancer, has immunosuppressive effect, and can be used as metal complexes for anticancer drugs.
North American market for Cisplatin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cisplatin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cisplatin in Testicular Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cisplatin include Eli Lilly and Company, Hospira, Pfizer, Bedford Pharmaceuticals, Alvogen, Athenex Pharmaceutical, Gland Pharma (Fosun Pharma), West-Ward Pharmaceuticals, WG Critical Care, David Bull Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cisplatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cisplatin.
The Cisplatin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cisplatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cisplatin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cisplatin Market Report

Report Metric Details
Report Name Cisplatin Market
Segment by Type
  • Tablets
  • Injection
Segment by Application
  • Testicular Cancer
  • Osteosarcoma
  • Breast Cancer
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly and Company, Hospira, Pfizer, Bedford Pharmaceuticals, Alvogen, Athenex Pharmaceutical, Gland Pharma (Fosun Pharma), West-Ward Pharmaceuticals, WG Critical Care, David Bull Laboratories, Omega Laboratories, Fresenius Kabi, TEVA, Mylan Pharmaceuticals, Yunnan Plant Pharmaceutical, Yunnan Biological Valley Pharmaceutical, Dezhou de Pharmaceutical, Jiangsu Haosen Pharmaceutical Group, Qilu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cisplatin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cisplatin Market report?

Ans: The main players in the Cisplatin Market are Eli Lilly and Company, Hospira, Pfizer, Bedford Pharmaceuticals, Alvogen, Athenex Pharmaceutical, Gland Pharma (Fosun Pharma), West-Ward Pharmaceuticals, WG Critical Care, David Bull Laboratories, Omega Laboratories, Fresenius Kabi, TEVA, Mylan Pharmaceuticals, Yunnan Plant Pharmaceutical, Yunnan Biological Valley Pharmaceutical, Dezhou de Pharmaceutical, Jiangsu Haosen Pharmaceutical Group, Qilu Pharmaceutical

What are the Application segmentation covered in the Cisplatin Market report?

Ans: The Applications covered in the Cisplatin Market report are Testicular Cancer, Osteosarcoma, Breast Cancer

What are the Type segmentation covered in the Cisplatin Market report?

Ans: The Types covered in the Cisplatin Market report are Tablets, Injection

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cisplatin Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Cisplatin Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cisplatin Market Perspective (2020-2031)
2.2 Global Cisplatin Growth Trends by Region
2.2.1 Global Cisplatin Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cisplatin Historic Market Size by Region (2020-2025)
2.2.3 Cisplatin Forecasted Market Size by Region (2026-2031)
2.3 Cisplatin Market Dynamics
2.3.1 Cisplatin Industry Trends
2.3.2 Cisplatin Market Drivers
2.3.3 Cisplatin Market Challenges
2.3.4 Cisplatin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cisplatin Players by Revenue
3.1.1 Global Top Cisplatin Players by Revenue (2020-2025)
3.1.2 Global Cisplatin Revenue Market Share by Players (2020-2025)
3.2 Global Cisplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cisplatin Revenue
3.4 Global Cisplatin Market Concentration Ratio
3.4.1 Global Cisplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cisplatin Revenue in 2024
3.5 Global Key Players of Cisplatin Head office and Area Served
3.6 Global Key Players of Cisplatin, Product and Application
3.7 Global Key Players of Cisplatin, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cisplatin Breakdown Data by Type
4.1 Global Cisplatin Historic Market Size by Type (2020-2025)
4.2 Global Cisplatin Forecasted Market Size by Type (2026-2031)
5 Cisplatin Breakdown Data by Application
5.1 Global Cisplatin Historic Market Size by Application (2020-2025)
5.2 Global Cisplatin Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cisplatin Market Size (2020-2031)
6.2 North America Cisplatin Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cisplatin Market Size by Country (2020-2025)
6.4 North America Cisplatin Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cisplatin Market Size (2020-2031)
7.2 Europe Cisplatin Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cisplatin Market Size by Country (2020-2025)
7.4 Europe Cisplatin Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cisplatin Market Size (2020-2031)
8.2 Asia-Pacific Cisplatin Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cisplatin Market Size by Region (2020-2025)
8.4 Asia-Pacific Cisplatin Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cisplatin Market Size (2020-2031)
9.2 Latin America Cisplatin Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cisplatin Market Size by Country (2020-2025)
9.4 Latin America Cisplatin Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cisplatin Market Size (2020-2031)
10.2 Middle East & Africa Cisplatin Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cisplatin Market Size by Country (2020-2025)
10.4 Middle East & Africa Cisplatin Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Cisplatin Introduction
11.1.4 Eli Lilly and Company Revenue in Cisplatin Business (2020-2025)
11.1.5 Eli Lilly and Company Recent Development
11.2 Hospira
11.2.1 Hospira Company Details
11.2.2 Hospira Business Overview
11.2.3 Hospira Cisplatin Introduction
11.2.4 Hospira Revenue in Cisplatin Business (2020-2025)
11.2.5 Hospira Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cisplatin Introduction
11.3.4 Pfizer Revenue in Cisplatin Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Bedford Pharmaceuticals
11.4.1 Bedford Pharmaceuticals Company Details
11.4.2 Bedford Pharmaceuticals Business Overview
11.4.3 Bedford Pharmaceuticals Cisplatin Introduction
11.4.4 Bedford Pharmaceuticals Revenue in Cisplatin Business (2020-2025)
11.4.5 Bedford Pharmaceuticals Recent Development
11.5 Alvogen
11.5.1 Alvogen Company Details
11.5.2 Alvogen Business Overview
11.5.3 Alvogen Cisplatin Introduction
11.5.4 Alvogen Revenue in Cisplatin Business (2020-2025)
11.5.5 Alvogen Recent Development
11.6 Athenex Pharmaceutical
11.6.1 Athenex Pharmaceutical Company Details
11.6.2 Athenex Pharmaceutical Business Overview
11.6.3 Athenex Pharmaceutical Cisplatin Introduction
11.6.4 Athenex Pharmaceutical Revenue in Cisplatin Business (2020-2025)
11.6.5 Athenex Pharmaceutical Recent Development
11.7 Gland Pharma (Fosun Pharma)
11.7.1 Gland Pharma (Fosun Pharma) Company Details
11.7.2 Gland Pharma (Fosun Pharma) Business Overview
11.7.3 Gland Pharma (Fosun Pharma) Cisplatin Introduction
11.7.4 Gland Pharma (Fosun Pharma) Revenue in Cisplatin Business (2020-2025)
11.7.5 Gland Pharma (Fosun Pharma) Recent Development
11.8 West-Ward Pharmaceuticals
11.8.1 West-Ward Pharmaceuticals Company Details
11.8.2 West-Ward Pharmaceuticals Business Overview
11.8.3 West-Ward Pharmaceuticals Cisplatin Introduction
11.8.4 West-Ward Pharmaceuticals Revenue in Cisplatin Business (2020-2025)
11.8.5 West-Ward Pharmaceuticals Recent Development
11.9 WG Critical Care
11.9.1 WG Critical Care Company Details
11.9.2 WG Critical Care Business Overview
11.9.3 WG Critical Care Cisplatin Introduction
11.9.4 WG Critical Care Revenue in Cisplatin Business (2020-2025)
11.9.5 WG Critical Care Recent Development
11.10 David Bull Laboratories
11.10.1 David Bull Laboratories Company Details
11.10.2 David Bull Laboratories Business Overview
11.10.3 David Bull Laboratories Cisplatin Introduction
11.10.4 David Bull Laboratories Revenue in Cisplatin Business (2020-2025)
11.10.5 David Bull Laboratories Recent Development
11.11 Omega Laboratories
11.11.1 Omega Laboratories Company Details
11.11.2 Omega Laboratories Business Overview
11.11.3 Omega Laboratories Cisplatin Introduction
11.11.4 Omega Laboratories Revenue in Cisplatin Business (2020-2025)
11.11.5 Omega Laboratories Recent Development
11.12 Fresenius Kabi
11.12.1 Fresenius Kabi Company Details
11.12.2 Fresenius Kabi Business Overview
11.12.3 Fresenius Kabi Cisplatin Introduction
11.12.4 Fresenius Kabi Revenue in Cisplatin Business (2020-2025)
11.12.5 Fresenius Kabi Recent Development
11.13 TEVA
11.13.1 TEVA Company Details
11.13.2 TEVA Business Overview
11.13.3 TEVA Cisplatin Introduction
11.13.4 TEVA Revenue in Cisplatin Business (2020-2025)
11.13.5 TEVA Recent Development
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Details
11.14.2 Mylan Pharmaceuticals Business Overview
11.14.3 Mylan Pharmaceuticals Cisplatin Introduction
11.14.4 Mylan Pharmaceuticals Revenue in Cisplatin Business (2020-2025)
11.14.5 Mylan Pharmaceuticals Recent Development
11.15 Yunnan Plant Pharmaceutical
11.15.1 Yunnan Plant Pharmaceutical Company Details
11.15.2 Yunnan Plant Pharmaceutical Business Overview
11.15.3 Yunnan Plant Pharmaceutical Cisplatin Introduction
11.15.4 Yunnan Plant Pharmaceutical Revenue in Cisplatin Business (2020-2025)
11.15.5 Yunnan Plant Pharmaceutical Recent Development
11.16 Yunnan Biological Valley Pharmaceutical
11.16.1 Yunnan Biological Valley Pharmaceutical Company Details
11.16.2 Yunnan Biological Valley Pharmaceutical Business Overview
11.16.3 Yunnan Biological Valley Pharmaceutical Cisplatin Introduction
11.16.4 Yunnan Biological Valley Pharmaceutical Revenue in Cisplatin Business (2020-2025)
11.16.5 Yunnan Biological Valley Pharmaceutical Recent Development
11.17 Dezhou de Pharmaceutical
11.17.1 Dezhou de Pharmaceutical Company Details
11.17.2 Dezhou de Pharmaceutical Business Overview
11.17.3 Dezhou de Pharmaceutical Cisplatin Introduction
11.17.4 Dezhou de Pharmaceutical Revenue in Cisplatin Business (2020-2025)
11.17.5 Dezhou de Pharmaceutical Recent Development
11.18 Jiangsu Haosen Pharmaceutical Group
11.18.1 Jiangsu Haosen Pharmaceutical Group Company Details
11.18.2 Jiangsu Haosen Pharmaceutical Group Business Overview
11.18.3 Jiangsu Haosen Pharmaceutical Group Cisplatin Introduction
11.18.4 Jiangsu Haosen Pharmaceutical Group Revenue in Cisplatin Business (2020-2025)
11.18.5 Jiangsu Haosen Pharmaceutical Group Recent Development
11.19 Qilu Pharmaceutical
11.19.1 Qilu Pharmaceutical Company Details
11.19.2 Qilu Pharmaceutical Business Overview
11.19.3 Qilu Pharmaceutical Cisplatin Introduction
11.19.4 Qilu Pharmaceutical Revenue in Cisplatin Business (2020-2025)
11.19.5 Qilu Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eli Lilly and Company
Hospira
Pfizer Inc
Bedford Pharmaceuticals
Alvogen
Athenex Pharmaceutical
Gland Pharma (Fosun Pharma)
West Ward Pharmaceuticals
WG Critical Care
David Bull Laboratories
Omega Laboratories
Fresenius Kabi
TEVA
Mylan Pharmaceuticals
Yunnan Plant Pharmaceutical
Yunnan Biological Valley Pharmaceutical
Dezhou de Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Qilu Pharmaceutical
List of Tables
 Table 1. Global Cisplatin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tablets
 Table 3. Key Players of Injection
 Table 4. Global Cisplatin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cisplatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cisplatin Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cisplatin Market Share by Region (2020-2025)
 Table 8. Global Cisplatin Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cisplatin Market Share by Region (2026-2031)
 Table 10. Cisplatin Market Trends
 Table 11. Cisplatin Market Drivers
 Table 12. Cisplatin Market Challenges
 Table 13. Cisplatin Market Restraints
 Table 14. Global Cisplatin Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cisplatin Market Share by Players (2020-2025)
 Table 16. Global Top Cisplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cisplatin as of 2024)
 Table 17. Ranking of Global Top Cisplatin Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cisplatin Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cisplatin, Headquarters and Area Served
 Table 20. Global Key Players of Cisplatin, Product and Application
 Table 21. Global Key Players of Cisplatin, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cisplatin Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cisplatin Revenue Market Share by Type (2020-2025)
 Table 25. Global Cisplatin Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cisplatin Revenue Market Share by Type (2026-2031)
 Table 27. Global Cisplatin Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cisplatin Revenue Market Share by Application (2020-2025)
 Table 29. Global Cisplatin Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cisplatin Revenue Market Share by Application (2026-2031)
 Table 31. North America Cisplatin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cisplatin Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cisplatin Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cisplatin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cisplatin Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cisplatin Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cisplatin Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cisplatin Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cisplatin Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cisplatin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cisplatin Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cisplatin Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cisplatin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cisplatin Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cisplatin Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Eli Lilly and Company Company Details
 Table 47. Eli Lilly and Company Business Overview
 Table 48. Eli Lilly and Company Cisplatin Product
 Table 49. Eli Lilly and Company Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 50. Eli Lilly and Company Recent Development
 Table 51. Hospira Company Details
 Table 52. Hospira Business Overview
 Table 53. Hospira Cisplatin Product
 Table 54. Hospira Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 55. Hospira Recent Development
 Table 56. Pfizer Company Details
 Table 57. Pfizer Business Overview
 Table 58. Pfizer Cisplatin Product
 Table 59. Pfizer Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 60. Pfizer Recent Development
 Table 61. Bedford Pharmaceuticals Company Details
 Table 62. Bedford Pharmaceuticals Business Overview
 Table 63. Bedford Pharmaceuticals Cisplatin Product
 Table 64. Bedford Pharmaceuticals Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 65. Bedford Pharmaceuticals Recent Development
 Table 66. Alvogen Company Details
 Table 67. Alvogen Business Overview
 Table 68. Alvogen Cisplatin Product
 Table 69. Alvogen Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 70. Alvogen Recent Development
 Table 71. Athenex Pharmaceutical Company Details
 Table 72. Athenex Pharmaceutical Business Overview
 Table 73. Athenex Pharmaceutical Cisplatin Product
 Table 74. Athenex Pharmaceutical Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 75. Athenex Pharmaceutical Recent Development
 Table 76. Gland Pharma (Fosun Pharma) Company Details
 Table 77. Gland Pharma (Fosun Pharma) Business Overview
 Table 78. Gland Pharma (Fosun Pharma) Cisplatin Product
 Table 79. Gland Pharma (Fosun Pharma) Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 80. Gland Pharma (Fosun Pharma) Recent Development
 Table 81. West-Ward Pharmaceuticals Company Details
 Table 82. West-Ward Pharmaceuticals Business Overview
 Table 83. West-Ward Pharmaceuticals Cisplatin Product
 Table 84. West-Ward Pharmaceuticals Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 85. West-Ward Pharmaceuticals Recent Development
 Table 86. WG Critical Care Company Details
 Table 87. WG Critical Care Business Overview
 Table 88. WG Critical Care Cisplatin Product
 Table 89. WG Critical Care Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 90. WG Critical Care Recent Development
 Table 91. David Bull Laboratories Company Details
 Table 92. David Bull Laboratories Business Overview
 Table 93. David Bull Laboratories Cisplatin Product
 Table 94. David Bull Laboratories Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 95. David Bull Laboratories Recent Development
 Table 96. Omega Laboratories Company Details
 Table 97. Omega Laboratories Business Overview
 Table 98. Omega Laboratories Cisplatin Product
 Table 99. Omega Laboratories Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 100. Omega Laboratories Recent Development
 Table 101. Fresenius Kabi Company Details
 Table 102. Fresenius Kabi Business Overview
 Table 103. Fresenius Kabi Cisplatin Product
 Table 104. Fresenius Kabi Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 105. Fresenius Kabi Recent Development
 Table 106. TEVA Company Details
 Table 107. TEVA Business Overview
 Table 108. TEVA Cisplatin Product
 Table 109. TEVA Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 110. TEVA Recent Development
 Table 111. Mylan Pharmaceuticals Company Details
 Table 112. Mylan Pharmaceuticals Business Overview
 Table 113. Mylan Pharmaceuticals Cisplatin Product
 Table 114. Mylan Pharmaceuticals Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 115. Mylan Pharmaceuticals Recent Development
 Table 116. Yunnan Plant Pharmaceutical Company Details
 Table 117. Yunnan Plant Pharmaceutical Business Overview
 Table 118. Yunnan Plant Pharmaceutical Cisplatin Product
 Table 119. Yunnan Plant Pharmaceutical Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 120. Yunnan Plant Pharmaceutical Recent Development
 Table 121. Yunnan Biological Valley Pharmaceutical Company Details
 Table 122. Yunnan Biological Valley Pharmaceutical Business Overview
 Table 123. Yunnan Biological Valley Pharmaceutical Cisplatin Product
 Table 124. Yunnan Biological Valley Pharmaceutical Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 125. Yunnan Biological Valley Pharmaceutical Recent Development
 Table 126. Dezhou de Pharmaceutical Company Details
 Table 127. Dezhou de Pharmaceutical Business Overview
 Table 128. Dezhou de Pharmaceutical Cisplatin Product
 Table 129. Dezhou de Pharmaceutical Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 130. Dezhou de Pharmaceutical Recent Development
 Table 131. Jiangsu Haosen Pharmaceutical Group Company Details
 Table 132. Jiangsu Haosen Pharmaceutical Group Business Overview
 Table 133. Jiangsu Haosen Pharmaceutical Group Cisplatin Product
 Table 134. Jiangsu Haosen Pharmaceutical Group Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 135. Jiangsu Haosen Pharmaceutical Group Recent Development
 Table 136. Qilu Pharmaceutical Company Details
 Table 137. Qilu Pharmaceutical Business Overview
 Table 138. Qilu Pharmaceutical Cisplatin Product
 Table 139. Qilu Pharmaceutical Revenue in Cisplatin Business (2020-2025) & (US$ Million)
 Table 140. Qilu Pharmaceutical Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Cisplatin Picture
 Figure 2. Global Cisplatin Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cisplatin Market Share by Type: 2024 VS 2031
 Figure 4. Tablets Features
 Figure 5. Injection Features
 Figure 6. Global Cisplatin Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cisplatin Market Share by Application: 2024 VS 2031
 Figure 8. Testicular Cancer Case Studies
 Figure 9. Osteosarcoma Case Studies
 Figure 10. Breast Cancer Case Studies
 Figure 11. Cisplatin Report Years Considered
 Figure 12. Global Cisplatin Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Cisplatin Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cisplatin Market Share by Region: 2024 VS 2031
 Figure 15. Global Cisplatin Market Share by Players in 2024
 Figure 16. Global Top Cisplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cisplatin as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Cisplatin Revenue in 2024
 Figure 18. North America Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Cisplatin Market Share by Country (2020-2031)
 Figure 20. United States Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cisplatin Market Share by Country (2020-2031)
 Figure 24. Germany Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cisplatin Market Share by Region (2020-2031)
 Figure 32. China Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cisplatin Market Share by Country (2020-2031)
 Figure 40. Mexico Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cisplatin Market Share by Country (2020-2031)
 Figure 44. Turkey Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Cisplatin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Eli Lilly and Company Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 48. Hospira Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 49. Pfizer Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 50. Bedford Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 51. Alvogen Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 52. Athenex Pharmaceutical Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 53. Gland Pharma (Fosun Pharma) Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 54. West-Ward Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 55. WG Critical Care Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 56. David Bull Laboratories Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 57. Omega Laboratories Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 58. Fresenius Kabi Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 59. TEVA Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 60. Mylan Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 61. Yunnan Plant Pharmaceutical Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 62. Yunnan Biological Valley Pharmaceutical Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 63. Dezhou de Pharmaceutical Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 64. Jiangsu Haosen Pharmaceutical Group Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 65. Qilu Pharmaceutical Revenue Growth Rate in Cisplatin Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Platinum based Cancer Drug Market Insights Forecast to 2030
Cisplatin Chemotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Platinum based Anticancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Platinum Compounds Market Research Report 2024
Global Cisplatin API Market Research Report 2024
Global Oxaliplatin Market Research Report 2025
Global Platinum based Antineoplastic Market Research Report 2025
Global Cis diiododiammineplatinum Market Research Report 2024
Global Neuroblastoma Chemotherapy Drugs Market Research Report 2025
Platinum Anti tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tetraammine Platinum Compounds Market Research Report 2024
Global Platinum Chloride Market Research Report 2024
Global Ammonium Hexachloroplatinate Market Research Report 2024
Global Chloroplatinic Acid Market Insights Forecast to 2030
Cyclophosphamide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tetraammine Platinum II Chloride Market Research Report 2024
Global Trimethyl methylcyclopentadienyl Platinum IV Market Research Report 2024
Global Platinum Catalyst Market Research Report 2024
Global Colloidal Platinum Market Research Report 2024
Global Platinum Acetylacetonate Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions